170 related articles for article (PubMed ID: 20101184)
1. Clozapine therapy raises serum concentrations of high sensitive C-reactive protein in schizophrenic patients.
Löffler S; Löffler-Ensgraber M; Fehsel K; Klimke A
Int Clin Psychopharmacol; 2010 Mar; 25(2):101-6. PubMed ID: 20101184
[TBL] [Abstract][Full Text] [Related]
2. Effects of clozapine on sleep: a longitudinal study.
Hinze-Selch D; Mullington J; Orth A; Lauer CJ; Pollmächer T
Biol Psychiatry; 1997 Aug; 42(4):260-6. PubMed ID: 9270902
[TBL] [Abstract][Full Text] [Related]
3. [Long-term clinical experience with clozapine].
Gelly F; Chambon O; Marie-Cardine M
Encephale; 1997; 23(5):385-96. PubMed ID: 9453932
[TBL] [Abstract][Full Text] [Related]
4. Association of blood levels of C-reactive protein with clinical phenotypes in Arab schizophrenic patients.
Akanji AO; Ohaeri JU; Al-Shammri S; Fatania HR
Psychiatry Res; 2009 Aug; 169(1):56-61. PubMed ID: 19619902
[TBL] [Abstract][Full Text] [Related]
5. [Presentation of obsessive-compulsive symptoms in a patient with schizophrenia treated with clozapine].
Stengler-Wenzke K
Psychiatr Prax; 1999 May; 26(3):145-6. PubMed ID: 10412713
[TBL] [Abstract][Full Text] [Related]
6. [Weight gain and clozapine].
Jalenques I; Tauveron I; Albuisson E; Audy V
Encephale; 1996 Oct; 22 Spec No 3():77-9. PubMed ID: 8954282
[No Abstract] [Full Text] [Related]
7. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels.
Freudenreich O; Weiner RD; McEvoy JP
Biol Psychiatry; 1997 Jul; 42(2):132-7. PubMed ID: 9209730
[TBL] [Abstract][Full Text] [Related]
8. Clozapine maintenance therapy in schizophrenia.
Gaszner P; Makkos Z
Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
[TBL] [Abstract][Full Text] [Related]
9. Violence and schizophrenia: clozapine as a specific antiaggressive agent.
Buckley P; Bartell J; Donenwirth K; Lee S; Torigoe F; Schulz SC
Bull Am Acad Psychiatry Law; 1995; 23(4):607-11. PubMed ID: 8639988
[TBL] [Abstract][Full Text] [Related]
10. Clozapine-induced QEEG changes correlate with clinical response in schizophrenic patients: a prospective, longitudinal study.
Gross A; Joutsiniemi SL; Rimon R; Appelberg B
Pharmacopsychiatry; 2004 May; 37(3):119-22. PubMed ID: 15138895
[TBL] [Abstract][Full Text] [Related]
11. Clozapine in patients with chronic schizophrenia: serum level, EEG and memory performance.
Adler G; Grieshaber S; Faude V; Thebaldi B; Dressing H
Pharmacopsychiatry; 2002 Sep; 35(5):190-4. PubMed ID: 12237790
[TBL] [Abstract][Full Text] [Related]
12. Clozapine withdrawal symptoms after change to sertindole in a schizophrenic patient.
Berecz R; Glaub T; Kellermann M; de la Rubia A; Llerena A; Degrell I
Pharmacopsychiatry; 2000 Jan; 33(1):42-4. PubMed ID: 10721883
[TBL] [Abstract][Full Text] [Related]
13. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
[TBL] [Abstract][Full Text] [Related]
14. [Effect of clozapine on biogenic amines within the scope of drug treatment of schizophrenic psychoses in adolescence].
Schulz E; Remschmidt H; Fleischhaker C
Z Kinder Jugendpsychiatr; 1994 Dec; 22(4):285-98. PubMed ID: 7856324
[TBL] [Abstract][Full Text] [Related]
15. Clozapine for refractory schizophrenia: an open study of 14 patients treated up to 2 years.
Mattes JA
J Clin Psychiatry; 1989 Oct; 50(10):389-91. PubMed ID: 2571612
[TBL] [Abstract][Full Text] [Related]
16. Infection-associated clozapine toxicity.
Darling P; Huthwaite MA
Clin Schizophr Relat Psychoses; 2011 Oct; 5(3):159-60. PubMed ID: 21983501
[TBL] [Abstract][Full Text] [Related]
17. [Medico-economic evaluation of treatment with clozapine versus treatment with previous neuroleptics].
Geronimi-Ferret D; Lesay M; Barges-Bertocchio MH; Cornet-Bonnefont M; Robert H
Encephale; 1997 Sep; 23 Spec No 4():24-31. PubMed ID: 9417402
[TBL] [Abstract][Full Text] [Related]
18. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine.
Friedman J; Ault K; Powchik P
Biol Psychiatry; 1997 Sep; 42(6):522-3. PubMed ID: 9285089
[No Abstract] [Full Text] [Related]
19. [Clozapine and treatment of negative symptoms].
Lançon C; Farisse J; Llorca PM
Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
Zink M; Kuwilsky A; Krumm B; Dressing H
J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
